MRI of OATP-expressing transplanted cells using clinical doses of gadolinium contrast agent
T. Bhattacharyya, C. L. Mallett, J. M.- L. Hix, E. M. Shapiro
The paper demonstrates that low-dose Gd-based contrast agents can enhance MRI signals in OATP-expressing tumors, distinguishable from non-expressing tumors via AUC analysis of DCE-MRI.
bioRxiv · Aug 7, 2023 · PreprintBioengineering